Neoadjuvant and Adjuvant Therapy for Gastrointestinal Tumors
Charlesse Pondt and Lakshmi Rajdev*
Montefiore Medical Center for Cancer Care, 1695 Eastchester Rd Bronx, NY 10461, USA
- *Corresponding Author:
- Lakshmi Rajdev
Montefiore Medical Center for Cancer Care 1695 Eastchester Rd Bronx
NY 10461, USA
E-mail: [email protected]
Received date: March 11, 2014; Accepted date: April 25, 2014; Published date: April 30, 2014
Citation: Pondt C, Rajdev L (2014) Neoadjuvant and Adjuvant Therapy for Gastrointestinal Tumors. J Gastroint Dig Syst 4:176. doi:10.4172/2161-069X.1000176
Copyright: © 2014 Pondt C, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Gastrointestinal tumors are the most common of a rare group of cancers known as mesenchymal tumors. New advances over the last several years have lead to the availability of targeted therapies in cancer and greater survival, particularly in this cancer type. This paper is a review of the current practices and treatments now utilized in the management of gastrointestinal tumors. Special emphasis was placed on treatment in Neoadjuvant and adjuvant settings. Research was conducted by inputting the words “GIST” “neoadjuvant”, and “adjuvant” into the Cochran, Pubmed, and Ovid Database up to December 2013.